These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3882654)

  • 1. In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content.
    Kitzis MD; Gutmann L; Acar JF
    J Antimicrob Chemother; 1985 Jan; 15(1):23-30. PubMed ID: 3882654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro susceptibility of pathogenic Nocardia to beta-lactam antibiotics, especially imipenem, a carbapenem antibiotic].
    Yazawa K; Mikami Y; Otozai K; Uno J; Arai T
    Jpn J Antibiot; 1989 Nov; 42(11):2354-62. PubMed ID: 2695658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A; Riou JY; Guibourdenche M; Sotolongo F
    Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.
    Steingrube VA; Wallace RJ; Brown BA; Pang Y; Zeluff B; Steele LC; Zhang Y
    Antimicrob Agents Chemother; 1991 Mar; 35(3):524-8. PubMed ID: 2039203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid.
    Wallace RJ; Nash DR; Johnson WK; Steele LC; Steingrube VA
    J Infect Dis; 1987 Dec; 156(6):959-66. PubMed ID: 3500241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.
    Aldridge KE; Sanders CV; Marier RL
    J Antimicrob Chemother; 1986 Apr; 17(4):463-9. PubMed ID: 3011724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
    García-Rodríguez JA; García Sánchez JE; García García MI; García Sánchez E; Muñoz Bellido JL
    Diagn Microbiol Infect Dis; 1991; 14(3):239-43. PubMed ID: 1889176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organisms.
    Bolivar R; Weaver SS; Bodey GP
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3):255-60. PubMed ID: 6086213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility.
    Lacroix JM; Lamothe F; Malouin F
    Antimicrob Agents Chemother; 1984 Nov; 26(5):694-8. PubMed ID: 6335019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME; Fu KP; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production.
    Crosby MA; Gump DW
    Antimicrob Agents Chemother; 1982 Sep; 22(3):398-405. PubMed ID: 6291451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases.
    Stobberingh EE; Davies BI; van Boven CP
    J Antimicrob Chemother; 1984 Jan; 13(1):55-64. PubMed ID: 6607919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of beta-lactams combined with beta-lactamase inhibitors against methicillin-resistant Staphylococcus aureus.
    Kobayashi S; Arai S; Hayashi S; Sakaguchi T
    Antimicrob Agents Chemother; 1989 Mar; 33(3):331-5. PubMed ID: 2786369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between beta-lactamase activity and resistance to beta-lactam antibiotics in Mycobacterium smegmatis.
    Yabu K; Kaneda S; Ochiai T
    Microbiol Immunol; 1985; 29(9):803-9. PubMed ID: 3877858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams.
    Gutmann L; Goldstein FW; Kitzis MD; Hautefort B; Darmon C; Acar JF
    Antimicrob Agents Chemother; 1983 Feb; 23(2):248-51. PubMed ID: 6340602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase.
    Bush K; Flamm RK; Ohringer S; Singer SB; Summerill R; Bonner DP
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2203-8. PubMed ID: 1803992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-lactamase inhibitors from laboratory to clinic.
    Bush K
    Clin Microbiol Rev; 1988 Jan; 1(1):109-23. PubMed ID: 3060240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of beta-lactamase inhibitors.
    Sutherland R
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.
    Maskell JP; Nasu M; Williams JD
    J Antimicrob Chemother; 1984 Jan; 13(1):23-30. PubMed ID: 6607916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.